行情

CVM

CVM

CEL SCI
AMEX

实时行情|Nasdaq Last Sale

13.52
-0.44
-3.15%
交易中 11:52 01/27 EST
开盘
12.71
昨收
13.96
最高
13.95
最低
12.57
成交量
51.26万
成交额
--
52周最高
15.00
52周最低
2.367
市值
4.87亿
市盈率(TTM)
-19.7142
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CVM 新闻

  • 法国财长:与美国在解决数字税的共同框架上达成一致
  • 新浪美股.5天前
  • 瑞银、摩根士丹利等大行将削减亚洲投资银行家奖金
  • 新浪美股.5天前
  • 尚乘智慧亚洲峰会:智慧亚洲-连接大湾区与东盟
  • 新浪财经.5天前
  • 美国二手房折合年率销量达到近两年来最高
  • 新浪美股.5天前

更多

所属板块

生物技术和医学研究
-0.99%
制药与医学研究
-0.47%

热门股票

名称
价格
涨跌幅

CVM 简况

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.
展开

Webull提供CEL-SCI Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。